These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26544121)

  • 1. An unusual business.
    Nat Biotechnol; 2015 Nov; 33(11):1113. PubMed ID: 26544121
    [No Abstract]   [Full Text] [Related]  

  • 2. An absolute waste.
    Haley D
    Hosp Health Netw; 2002 May; 76(5):12. PubMed ID: 12035561
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct-to-consumer marketing.
    Hurst JW
    N Engl J Med; 2002 Jun; 346(25):2011; author reply 2012-3. PubMed ID: 12078709
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology 101 pop quiz.
    Zarbock S
    JAAPA; 2004 Feb; 17(2):13-4, 16. PubMed ID: 15307326
    [No Abstract]   [Full Text] [Related]  

  • 6. High drug costs seem to keep getting higher.
    Ackerman W
    J Ark Med Soc; 2005 Apr; 101(10):293. PubMed ID: 15839313
    [No Abstract]   [Full Text] [Related]  

  • 7. Screaming for relief.
    Cooper M
    Time; 1999 Nov; 154(21):38-42, 44. PubMed ID: 10622838
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the impact of free drug samples on patients?
    Downey LV
    South Med J; 2008 Sep; 101(9):879-80. PubMed ID: 18708974
    [No Abstract]   [Full Text] [Related]  

  • 9. DTC ads in US having huge impact on drug sales.
    Korcok M
    CMAJ; 2002 Aug; 167(3):289. PubMed ID: 12186182
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinton team works with drug companies to expand access, restrict costs.
    Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
    [No Abstract]   [Full Text] [Related]  

  • 11. AWP reimbursement scrutinized by several states.
    Carroll J
    Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
    [No Abstract]   [Full Text] [Related]  

  • 12. Industry warily eyes new Medicare drug plan.
    Vastag B
    Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic-class wars--drug promotion in a competitive marketplace.
    Kessler DA; Rose JL; Temple RJ; Schapiro R; Griffin JP
    N Engl J Med; 1994 Nov; 331(20):1350-3. PubMed ID: 7935706
    [No Abstract]   [Full Text] [Related]  

  • 14. The new drug war.
    Parloff R
    Fortune; 2004 Mar; 149(5):144-6, 148, 150 passim. PubMed ID: 15015428
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug importation not the right answer, Nobel economist says.
    Thompson CA
    Am J Health Syst Pharm; 2004 Mar; 61(6):546, 548. PubMed ID: 15061425
    [No Abstract]   [Full Text] [Related]  

  • 16. Medication assistance programs: eligibility and enrollment.
    Speicher G
    Arch Intern Med; 2002 Dec 9-23; 162(22):2629; author reply 2629-30. PubMed ID: 12456236
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent nonsense: evidence tells of an industry out of social control.
    Mintzberg H
    CMAJ; 2006 Aug; 175(4):374. PubMed ID: 16908900
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug companies offer major discounts to uninsured.
    Christenson V
    J Law Med Ethics; 2005; 33(2):399-403. PubMed ID: 16083101
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicare should bargain for lower drug prices, study says.
    Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.